Is there evidence for vasculitis in systemic sclerosis? (Q38052089)

27 August 2017

Is there evidence for vasculitis in systemic sclerosis? (English)

1 reference

27 August 2017

Lesley Ann Saketkoo

1

1 reference

PubMed ID

23065452

27 August 2017

Oliver Distler

series ordinal

2

1 reference

27 August 2017

1 December 2012

1 reference

Current Rheumatology Reports

27 August 2017

1 reference

27 August 2017

14

1 reference

27 August 2017

6

1 reference

27 August 2017

516-525

1 reference

https://scigraph.springernature.com/pub.10.1007/s11926-012-0296-9

27 August 2017

0 references

cites work

Clinical burden of digital vasculopathy in limited and diffuse cutaneous systemic sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0296-9

Radiological hand involvement in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0296-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0296-9

Gastric involvement in systemic sclerosis: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0296-9

Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0296-9

Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0296-9

Changes in causes of death in systemic sclerosis, 1972-2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0296-9

Involvement of functional autoantibodies against vascular receptors in systemic sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0296-9

Epidemiology of systemic sclerosis: incidence, prevalence, survival, risk factors, malignancy, and environmental triggers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0296-9

Retroviruses and the pathogenesis of systemic sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0296-9

Vascular disease in scleroderma: mechanisms of vascular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0296-9

Genetics of systemic sclerosis: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0296-9

IRF5 polymorphism predicts prognosis in patients with systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0296-9

EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0296-9

A growing need for capillaroscopy in rheumatology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0296-9

Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0296-9

Capillaroscopic pattern in systemic sclerosis - an association with dynamics of processes of angio- and vasculogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0296-9

Abnormal microvascular response is localized to the digits in patients with systemic sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0296-9

Distribution of macrovascular disease in scleroderma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0296-9

Ulnar artery occlusion is predictive of digital ulcers in SSc: a duplex sonography study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0296-9

Capillary regeneration in scleroderma: stem cell therapy reverses phenotype?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0296-9

Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0296-9

Anti-neutrophil antibody associated vasculitis in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0296-9

Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0296-9

Radical oxygen species production induced by advanced oxidation protein products predicts clinical evolution and response to treatment in systemic sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0296-9

Transforming growth factor-beta1 induces Nox4 NAD(P)H oxidase and reactive oxygen species-dependent proliferation in human pulmonary artery smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0296-9

Platelet-derived growth factor and reactive oxygen species (ROS) regulate Ras protein levels in primary human fibroblasts via ERK1/2. Amplification of ROS and Ras in systemic sclerosis fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0296-9

Endothelial progenitor cells: novel players in the pathogenesis of rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0296-9

EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0296-9

Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0296-9

Non-HLA-antibodies targeting Angiotensin type 1 receptor and antibody mediated rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0296-9

Agonistic autoantibodies directed against the angiotensin II AT1 receptor in patients with preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0296-9

Endothelin Receptor Antagonists for the Treatment of Raynaud's Phenomenon and Digital Ulcers in Systemic Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0296-9

Endothelin receptor antagonists for the treatment of pulmonary artery hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0296-9

Circulating endothelial progenitor cells, vascular function, and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0296-9

The differential expression of VEGF, VEGFR-2, and GLUT-1 proteins in disease subtypes of systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0296-9

Circulating endothelial progenitor cells in systemic sclerosis: association with disease severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0296-9

Angiogenic biomarkers predict the occurrence of digital ulcers in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0296-9

Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0296-9

Domain 1 of the urokinase-type plasminogen activator receptor is required for its morphologic and functional, beta2 integrin-mediated connection with actin cytoskeleton in human microvascular endothelial cells: failure of association in systemic scl

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0296-9

Hyperplasia of dermal microvascular pericytes in scleroderma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0296-9

Platelet-derived serotonin links vascular disease and tissue fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0296-9

Monocyte chemoattractant proteins in the pathogenesis of systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0296-9

Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0296-9

Insights into the pathogenesis of systemic sclerosis based on the gene expression profile of progenitor-derived endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0296-9

Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: A twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic scl

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0296-9

The plasminogen activator system in fibroblasts from systemic sclerosis

21 January 2018

1 reference

12 December 2020

Overexpression of monocyte chemoattractant protein 1 in systemic sclerosis: role of platelet-derived growth factor and effects on monocyte chemotaxis and collagen synthesis

1 reference

12 December 2020

Defective vasculogenesis in systemic sclerosis

1 reference

12 December 2020

Downregulation of miR-193b in systemic sclerosis regulates the proliferative vasculopathy by urokinase-type plasminogen activator expression.

1 reference

12 December 2020

Matrix metalloproteinase 12-dependent cleavage of urokinase receptor in systemic sclerosis microvascular endothelial cells results in impaired angiogenesis

1 reference

12 December 2020

Antiendothelial Cell Antibodies Induce Apoptosis of Bone Marrow Endothelial Progenitors in Systemic Sclerosis

1 reference

12 December 2020

Stimulatory Autoantibodies to the PDGF Receptor in Systemic Sclerosis

1 reference

12 December 2020

Anti-endothelial cell antibodies in systemic sclerosis: significant association with vascular involvement and alveolo-capillary impairment.

1 reference

12 December 2020

Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases

1 reference

12 December 2020

Vascular endothelial damage and repair in antineutrophil cytoplasmic antibody-associated vasculitis

1 reference

12 December 2020

Microvascular abnormalities in chronic heart failure: a cross-sectional analysis

1 reference

12 December 2020

The arthropathy of systemic sclerosis: a 12 month prospective clinical and imaging study

1 reference

12 December 2020

Modulation of the angiogenic phenotype of normal and systemic sclerosis endothelial cells by gain-loss of function of pentraxin 3 and matrix metalloproteinase 12

1 reference

12 December 2020

Electron microscopy and capillaroscopically guided nailfold biopsy in connective tissue diseases: detection of ultrastructural changes of the microcirculatory vessels.

1 reference

12 December 2020

Pericyte-specific expression of Rgs5: implications for PDGF and EDG receptor signaling during vascular maturation

1 reference

12 December 2020

Antineutrophil cytoplasmic autoantibodies in systemic sclerosis with renal failure

1 reference

12 December 2020

A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis

1 reference

12 December 2020

Quantification of circulating endothelial progenitor cells in systemic sclerosis: a direct comparison of protocols.

1 reference

12 December 2020

Autoantibodies to proteinase 3 and myeloperoxidase in systemic sclerosis.

1 reference

12 December 2020

Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease

1 reference

12 December 2020

Rarefaction of skin capillaries in borderline essential hypertension suggests an early structural abnormality

1 reference

12 December 2020

Bone marrow endothelial progenitors are defective in systemic sclerosis

1 reference

12 December 2020

Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis in scleroderma--a different kind of renal crisis

1 reference

12 December 2020

Induction of apoptosis in circulating angiogenic cells by microparticles

1 reference

12 December 2020

Increased serum levels of antibodies against human cytomegalovirus and prevalence of autoantibodies in systemic sclerosis

1 reference

12 December 2020

Limited scleroderma is associated with increased prevalence of macrovascular disease

1 reference

12 December 2020

Transcription factor fos-related antigen-2 induces progressive peripheral vasculopathy in mice closely resembling human systemic sclerosis

1 reference

12 December 2020

The influence of measurement location on reliability of quantitative nailfold videocapillaroscopy in patients with SSc

1 reference

12 December 2020

Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy

1 reference

12 December 2020

Induction of apoptosis and fibrillin 1 expression in human dermal endothelial cells by scleroderma sera containing anti-endothelial cell antibodies

1 reference

12 December 2020

The genetics of systemic sclerosis: an update.

1 reference

12 December 2020

10.1007/S11926-012-0296-9

Identifiers

DOI

1 reference

PubMed ID

23065452

Dimensions Publication ID

27 August 2017

0 references

1 reference

PubMed ID

23065452